Competitive Technologies Inc (CTTC)

 Competitive Technologies, Inc. (OTCQX: CTTC)
 

Distributor of Calmare--a non-invasive and non-narcotic chronic pain management medical device with FDA 510K Marketing Allowance

52 Week Trading Range: $0.24- $1.24
Shares Outstanding: 15.3 Million
Corporate Website: http://www.competitivetech.net
Calmare Website: www.calmarett.com
 

CALMARE VIDEOS

 US Military and VA Hospitals using Calmare: http://www.calmarett.com/locations/usmilitary.html

A recent feature story on Calmare aired on KSL-TV (http://www.ksl.com/?nid=148&sid=16580318).  

Deseret News article: (http://www.deseretnews.com/article/705388446/Device-used-by-southern-Utah-doctor-is-helping-people-live-a-life-without-constant-pain.html) highlighted the success Dr. Robert Chalmers of Utah had in treatment of a teenager who had suffered from severe pain from a nerve disorder called reflex neurovascular dystrophy, or RND, for nearly two years.

CTT's chronic pain management technology is indicated for drug resistant pain management by using external electric stimulation to manipulate the signals flowing to the central nervous system. When receiving Calmar Pain Relief Therapy (CPR-T), artificial neurons are created to non-invasively transmit to the central nervous system (CNS) information that is recognizable as 'self' and 'non-pain' through surface receptors on the skin

Compared to conventional electro-analgesia, the CPR-T principle substitutes pain information with synthetic 'non-pain' information, rather than blocking pain transmission as with TENS or implanted devices utilizing the Gate Control theory. The device incorporates electromedical equipment for electronic nerve stimulation, and uses the nerve fiber as a passive means to convey a message of normality to the central nervous system by a procedure defined as "Scrambling" or tricking of information, which then enables the central nervous system to modify the reflex adaptive responses. Since the device consists of a multiprocessor apparatus able to simulate five artificial neurons, it allows five pain areas to be treated simultaneously.